Dare Bioscience, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $38.8M | $51.7M |
| FY2022 | — | $11.1M | $34.7M |
| FY2023 | — | $-5.0M | $10.5M |
| FY2024 | — | $-6.0M | $15.7M |
| FY2025 | — | $2.8M | $24.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $38.8M | $51.7M |
| FY2022 | — | $11.1M | $34.7M |
| FY2023 | — | $-5.0M | $10.5M |
| FY2024 | — | $-6.0M | $15.7M |
| FY2025 | — | $2.8M | $24.7M |